{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T10:38:21Z","timestamp":1788777501373,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":860,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1002\/rth2.12392","type":"journal-article","created":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T03:30:06Z","timestamp":1594783806000},"page":"952-957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2103-1661","authenticated-orcid":false,"given":"Emmanuel J.","family":"Favaloro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1002\/rth2.12392_bb0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1538-7836.2009.03661.x","article-title":"The prevalence of symptomatic von Willebrand disease in primary care practice","volume":"8","author":"Bowman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1002\/rth2.12392_bb0015","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1002\/rth2.12392_bb0020","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/bjh.13064","article-title":"The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology","volume":"167","author":"Laffan","year":"2014","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1002\/rth2.12392_bb0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence\u2010based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"issue":"4","key":"10.1002\/rth2.12392_bb0030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pathol.2016.03.001","article-title":"Laboratory tests used to help diagnose von Willebrand disease: an update","volume":"48","author":"Favaloro","year":"2016","journal-title":"Pathology"},{"key":"10.1002\/rth2.12392_bb0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.thromres.2015.12.010","article-title":"Evaluation of a von Willebrand factor three test panel and chemiluminescent\u2010based assay system for identification of, and therapy monitoring in, von Willebrand disease","volume":"141","author":"Favaloro","year":"2016","journal-title":"Thromb Res"},{"key":"10.1002\/rth2.12392_bb0040","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/jth.12964","article-title":"Platelet\u2010dependent von Willebrand factor activity. Nomenclature and methodology: communication from the SSC of the ISTH","volume":"13","author":"Bodo","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1002\/rth2.12392_bb0045","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/978-1-4939-7196-1_33","article-title":"Laboratory testing for von Willebrand factor activity by glycoprotein Ib binding assays (VWF:GPIb)","volume":"1646","author":"Patzke","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1002\/rth2.12392_bb0050","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.thromres.2014.09.024","article-title":"Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays","volume":"134","author":"Favaloro","year":"2014","journal-title":"Thromb Res"},{"issue":"1","key":"10.1002\/rth2.12392_bb0055","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/ajh.24556","article-title":"Utility of the von Willebrand factor collagen binding assay in the diagnosis of von Willebrand disease","volume":"92","author":"Favaloro","year":"2017","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1002\/rth2.12392_bb0060","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1309\/AJCPH5JK4ONENPAE","article-title":"von Willebrand factor assay proficiency testing: the North American Specialized Coagulation Laboratory Association Experience","volume":"135","author":"Chandler","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1002\/rth2.12392_bb0065","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1055\/s-2006-947862","article-title":"An external quality assessment program for von Willebrand factor laboratory analysis: an overview from the European Concerted Action on Thrombosis and Disabilities Foundation","volume":"32","author":"Meijer","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10.1002\/rth2.12392_bb0070","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1055\/s-0031-1281028","article-title":"Von Willebrand disease: local diagnosis and management of a globally distributed bleeding disorder","volume":"37","author":"Favaloro","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1002\/rth2.12392_bb0075","article-title":"Navigating the myriad of von Willebrand factor (VWF) assays","author":"Favaloro","year":"2020","journal-title":"H\u00e4mostaseologie"},{"key":"10.1002\/rth2.12392_bb0080","unstructured":"Vangenechten I, Gadisseur A.Pathological reference ranges for VWF multimer distribution improve frontline VWD diagnosis and classification. RPTH current issue."},{"issue":"2","key":"10.1002\/rth2.12392_bb0085","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.thromres.2014.05.020","article-title":"Evaluating errors in the laboratory identification of von Willebrand disease in the real world","volume":"134","author":"Favaloro","year":"2014","journal-title":"Thromb Res"},{"issue":"4","key":"10.1002\/rth2.12392_bb0090","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1055\/s-0039-3402430","article-title":"Genetic background of von Willebrand disease: history, current state, and future perspectives","volume":"46","author":"Zolkova","year":"2020","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"10.1002\/rth2.12392_bb0095","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/hae.13957","article-title":"Comparative assessment of von Willebrand factor multimers vs activity for von Willebrand disease using modern contemporary methodologies","volume":"26","author":"Favaloro","year":"2020","journal-title":"Haemophilia"},{"issue":"4","key":"10.1002\/rth2.12392_bb0100","doi-asserted-by":"crossref","DOI":"10.1111\/hae.13261","article-title":"Evaluation of a new commercial von Willebrand factor multimer assay","volume":"23","author":"Favaloro","year":"2017","journal-title":"Haemophilia"},{"key":"10.1002\/rth2.12392_bb0105","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/978-1-4939-7196-1_36","article-title":"Laboratory testing for von Willebrand factor multimers","volume":"1646","author":"Oliver","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1002\/rth2.12392_bb0110","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/ijlh.13107","article-title":"Semi\u2010automated von Willebrand factor multimer assay for von Willebrand disease: further validation, benefits and limitations","volume":"41","author":"Oliver","year":"2019","journal-title":"Int J Lab Hematol"},{"issue":"6","key":"10.1002\/rth2.12392_bb0115","article-title":"Preclinical evaluation of a semi\u2010automated and rapid commercial electrophoresis assay for von Willebrand factor multimers","volume":"32","author":"Pikta","year":"2018","journal-title":"J ClinLab Analysis"},{"issue":"4","key":"10.1002\/rth2.12392_bb0120","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/rth2.12141","article-title":"Evaluation of a semi\u2010automated von Willebrand factor multimer assay, the Hydragel 5 von Willebrand multimer, by two European Centers","volume":"2","author":"Bowyer","year":"2018","journal-title":"Res Pract Thromb Haemost"},{"issue":"5","key":"10.1002\/rth2.12392_bb0125","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/ijlh.12869","article-title":"Evaluation of a new commercial method for von Willebrand factor multimeric analysis","volume":"40","author":"Crist","year":"2018","journal-title":"Int J Lab Hematol"},{"key":"10.1002\/rth2.12392_bb0130","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/978-1-4939-7196-1_35","article-title":"Ristocetin\u2010induced platelet aggregation (RIPA) and RIPA mixing studies","volume":"1646","author":"Frontroth","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"5","key":"10.1002\/rth2.12392_bb0135","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1055\/s-0036-1579641","article-title":"Type 2M and type 2A von Willebrand disease: similar but different","volume":"42","author":"Favaloro","year":"2016","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"10.1002\/rth2.12392_bb0140","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/hae.13929","article-title":"Evaluation of a fully automated von Willebrand factor assay panel for the diagnosis of von Willebrand disease","volume":"26","author":"Stufano","year":"2020","journal-title":"Haemophilia"},{"issue":"3","key":"10.1002\/rth2.12392_bb0145","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1111\/hae.12903","article-title":"Type 2M von Willebrand disease \u2013 more often misidentified than correctly identified","volume":"22","author":"Favaloro","year":"2016","journal-title":"Haemophilia"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Frth2.12392","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12392","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/rth2.12392","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922020702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037922020702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/rth2.12392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:19:24Z","timestamp":1762863564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037922020702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2475037922020702"],"URL":"https:\/\/doi.org\/10.1002\/rth2.12392","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Classification of von Willebrand disease in the context of modern contemporary von Willebrand factor testing methodologies","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/rth2.12392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The Authors. Research and Practice in Thrombosis and Haemostasis published by ELSEVIER INC. on behalf of International Society on Thrombosis and Haemostasis","name":"copyright","label":"Copyright"}]}}